National News

Dr Kartik Chandulal Bhadra appointed as an Independent Director of IRCON

The Board of Directors of IRCON have approved the appointment of Dr Kartik Chandulal Bhadra as an Independent Director of IRCON Ltd

PSU Watch Bureau

New Delhi: Dr Kartik Chandulal Bhadra has been appointed as an Independent Director on the Board of Ircon International Limited (IRCON), a Miniratna PSU under the Ministry of Railways. The Board of Directors of IRCON in its meeting held on January 5, has approved the appointment of Dr Bhadra as an Independent (Part-Time Non-Official) Director (Additional Director) on the Board of the company with effect from December 31, 2021. This information has been shared by the Miniratna Railway PSU in a regulatory filing to the stock exchanges on Wednesday.

Dr Bhadra, aged 55 years, is an MBBS. He is a Paediatrician Doctor in Kalrav Children Hospital in Valsad, Gujarat since 1991. He is not related to any other Director of the company.

Ircon International Limited (IRCON) is an engineering and construction organisation, specialized in transport infrastructure. The PSU was established in 1976, by the government under the Indian Companies Act 1956. IRCON was registered as the Indian Railway Construction International Ltd., a wholly (100%) owned entity of the Ministry of Railways. Its primary charter was the construction of railway projects in India and abroad.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)

Finland courts Indian circular economy partners ahead of Gandhinagar WCEF

India's crude oil import bill jumps 56.5% to $63.4 bn in April-July as volumes stay flat

PM Modi assures support to space startups, urges them to develop solutions for everyday needs

Bengaluru Airport: AERA slashes user development fee to Rs 300 for domestic passengers

Govt says 29 FDI proposals worth Rs 4,895.65 crore reported after easing 10% Chinese stake rule